ClinicalTrials.Veeva

Menu

Diaphragmatic Echography in COVID-19 Pneumonia (COVIDUSDIAP)

J

Javier Lázaro

Status

Completed

Conditions

Respiratory Failure
Covid19
Pneumonia, Viral

Treatments

Diagnostic Test: Diaphragmatic echography

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

We hypothesized that diaphragm thickness is concerned in acute respiratory failure of COVID19 patients and its ultrasound measure at the begining of hospitalisation is a good predictor of poor outcome.

A prospective observational non intervention study is designed.

Full description

To answer our hypothesis we will perform diaphragm ultrasound in the first 24hr hospitalized COVID19 patients.

In the ultrasound exploration we will assess diaphragm movility and thickness. We will also assess other clinical, biochemistry and radiological variables. The main outcome we want to analyze is the destination on discharge: home, respiratory intermediate critical unit or exitus.

Enrollment

171 patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COVID19 Pneumonia Acute respiratory failure (PaO2 <60mmHg)

Exclusion criteria

  • Invasive or non invasive ventilation within first 24h Neuromuscular disease Diaphragmatic paralysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems